Lung health in Canadians who use vaping devices
Official title: The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study
Run by University of British Columbia · NCT06819969 · Data updated 2026-11-12
This project will test new breathing tests, scans, and exercise measures to see if vaping harms the lungs of Canadian adolescents and adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 8 sites (Edmonton, Alberta and 7 other locations) |
| Status | Recruiting |
| Started | July 25, 2025 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT06819969 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Canadians who can attend a participating center and are either age 12–18 and never-smokers or exclusive e-cigarette users, or age 19+ and in one of four groups: never-users, exclusive cigarette smokers, exclusive e-cigarette users, or current dual users.
✕Probably not a fit
People with physician-diagnosed chronic lung disease, recent combustible cannabis use, recent cigarette smoking in adolescents, or those unable to complete pulmonary function and exercise testing may be excluded or are unlikely to gain direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CLOUD program is a pan-Canadian, multicentre, longitudinal effort that applies advanced imaging, novel pulmonary function tests, dynamic exercise testing, and airway cell sequencing to characterize vaping-related lung changes. It enrolls adolescents (12–18) and adults (19+) across user groups including never-users, exclusive e-cigarette users, exclusive cigarette smokers, and dual users. Participants undergo baseline and follow-up physiologic testing, imaging, exercise testing, and specimen collection to look specifically for small-airway injury. The study aims to define early signs of lung damage from vaping and improve detection across the lifespan.
Why it matters
Potential benefit: If successful, the project could identify early lung damage from vaping and give vapers and clinicians clearer information about risks and earlier detection.
How similar studies have gone: Prior case reports and smaller studies have linked vaping to lung injury, but comprehensive multicentre longitudinal phenotyping of small-airway disease using this combination of techniques is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adolescent arm: * Aged ≥12 and \<19 years old * Either 1) use neither combustible cigarettes nor e-cigarettes or 2) use e-cigarettes exclusively Adult arm: * Aged ≥19 years old * Fall into one of the following categories: 1) use neither combustible cigarettes nor e-cigarettes; 2) use combustible cigarettes exclusively, never using e-cigarettes; 3) use e-cigarettes exclusively, never using combustible cigarettes; or 4) use both combustible cigarettes and e-cigarettes currently Exclusion Criteria: Adolescent arm: * Contraindication to pulmonary function testing and cardiopulmonary exercise testing * Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year * Have smoked combustible cigarettes within the last 6 months * Have a physician-diagnosed chronic lung disease (such as asthma, cystic fibrosis, or bronchopulmonary dysplasia) * Inability to provide written informed consent Adult arm: * Contraindication to pulmonary function testing and cardiopulmonary exercise testing * Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year * Currently undergoing treatment for lung cancer * Inability to provide written informed consent No limitations will be placed on the type of e-liquids used by participants; e.g., e-cigarette users of nicotine, tetrahydrocannabinol, and cannabidiol will be all enrolled.
Where it's running
-
University of Alberta (Clinical Sciences Building)
Edmonton, Alberta, Canada Recruiting -
BC Cancer Agency
Vancouver, British Columbia, Canada Recruiting -
BC Children's Hospital Research Institute
Vancouver, British Columbia, Canada Recruiting -
St. Paul's Hospital
Vancouver, British Columbia, Canada Recruiting -
University of Ottawa (The Ottawa Hospital General Campus)
Ottawa, Ontario, Canada Recruiting -
McMaster University (Research Institute of St. Joe's Hamilton)
Hamilton, Ontario, Canada Not yet recruiting
Show 2 more locations
-
University of Toronto (The Hospital for Sick Children)
Toronto, Ontario, Canada Not yet recruiting -
Université de Sherbrooke
Sherbrooke, Quebec, Canada Not yet recruiting
Study contacts
- Principal investigator: Janice Leung, MD — University of British Columbia
- Study coordinator: Janice Leung, MD
- Email: janice.leung@hli.ubc.ca
- Phone: 604-836-0423
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
QuitVaping behavioral program with texting support to help teens stop vaping
This trial will try QuitVaping plus extra texting to see if it helps teens aged 14–18 who vape nicotine quit more than standard education and referral alone.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Social media support groups to help teens and young adults quit vaping
This pilot tries a social-media group program called the Quit the Hit Toolkit to help adolescents and young adults who vape stop using nicotine.
-
How synthetic nicotine and nicotine analogues behave in the body when vaped
This study tests synthetic nicotine and related nicotine analogues in vapes to see how they move through and act in the body compared with regular nicotine.
-
Parents Helping Parents for Youth Vaping Cessation
This project tests whether a parent-supported program can help teens quit vaping by pairing trained parent coaches with families.
-
E-cigarette Cessation for Hispanic/Latino Teens in Florida
This project tests a six-session, CBT-based e-cigarette cessation program tailored for Hispanic/Latino high school students to see if it helps reduce vaping use.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.